Aspironix Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
70
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Aspironix General Information
Description
Distributor of medical devices based in Prague, Czech Republic. The company distributes digital health, aesthetics, gynecology, wound healing, surgery, cardiology and radiology, mammary diagnostics, intensive care and ai diagnostics products.
Contact Information
Website
www.aspironix.com(Operating Subsidiary)
Corporate Office
- Hradčanské náměstí 12/60
- Prague, 118 00
- Czech Republic
Corporate Office
- Hradčanské náměstí 12/60
- Prague, 118 00
- Czech Republic
Aspironix Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Aspironix Executive Team (2)
Name | Title | Board Seat |
---|---|---|
Jiri Pavlicek | Founder, Director & Chief Executive Officer | |
Lubomir Franc | Chief Financial Officer |
Aspironix Signals
Aspironix FAQs
-
When was Aspironix founded?
Aspironix was founded in 2011.
-
Who is the founder of Aspironix?
Jiri Pavlicek is the founder of Aspironix.
-
Who is the CEO of Aspironix?
Jiri Pavlicek is the CEO of Aspironix.
-
Where is Aspironix headquartered?
Aspironix is headquartered in Prague, Czech Republic.
-
What is the size of Aspironix?
Aspironix has 70 total employees.
-
What industry is Aspironix in?
Aspironix’s primary industry is Distributors (Healthcare).
-
Is Aspironix a private or public company?
Aspironix is a Private company.
-
What is Aspironix’s current revenue?
The current revenue for Aspironix is
. -
When was Aspironix acquired?
Aspironix was acquired on 06-Aug-2024.
-
Who acquired Aspironix?
Aspironix was acquired by Asker Healthcare Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »